Skip to search.
 FTSE 100 Up 3.08%

VIVUS Inc. (VVUS)

-NasdaqGS
1.02 Up 0.05(5.15%) 12 Feb 20:59
Prev Close:0.97
Open:0.98
Bid:0.97 x 200
Ask:1.15 x 300
1y Target Est:8.27
Beta:0.299565
Earnings Date:22 Feb - 26 Feb (Est.)
Day's Range:0.96 - 1.07
52wk Range:0.92 - 3.14
Volume:1,422,635
Avg Vol (3m):1,308,330
Market Cap:106.12m
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for VVUS at this time.

Comparison

Symbol% ChgMkt Cap
VVUSUp 5.15%106.12m
LLYDown 0.21%75.47b
PFEUp 0.79%181.25b
GSKUp 1.56%96.22b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.95
Quarterly EPS Est (Dec-15) :-0.12
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-1.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback